LORENZATO, Annalisa
LORENZATO, Annalisa
ONCOLOGIA
Abstract 5900: Tolerance to colibactin correlates with response to chemotherapeutic agents in colorectal cancer
2023-01-01 Sogari, Alberto; Rovera, Emanuele; Reilly, Nicole Megan; Lamba, Simona; Russo, Mariangela; Lorenzato, Annalisa; Durinikova, Erika; Trusolino, Livio; Arena, Sabrina; Donalisio, Manuela; Nicolantonio, Federica Di; Lembo, David; Bardelli, Alberto
Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer
2023-01-01 Grasso, Gaia; Marriella, Elisa; Miotto, Martina; Buzo, Kristi; Reilly, Nicole M.; Andrei, Pietro; Vitiello, Pietro P.; Crisafulli, Giovanni; Arena, Sabrina; Rospo, Giuseppe; Corti, Giorgio; Lorenzato, Annalisa; Cancelliere, Carlotta; Barault, Ludovic; Gionfriddo, Giulia; Linnebacher, Michael; Russo, Mariangela; Nicolantonio, Federica Di; Bardelli, Alberto
Cisplatin unveils cancer cell addiction to the non-oncogene CDT2
2009-01-01 Olivero M; Dettori D; Lorenzato A; Martino C; Musiani D; Orlando G; Di Renzo MF
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin
2010-01-01 Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF
Genetics in renal cancer
2008-01-01 M. Olivero; A. Lorenzato; Di Renzo MF
MET-oncogene transforms human bone-derived cells by targeting committed progenitors.
2010-01-01 Dani N; Olivero M; Lorenzato A; Cuvertino S; Patane’ S; Van Duist M; Mareschi K; Fagioli F; Di Renzo MF
P38MAPK highlights the dark side of Met/HGF pathway in ovarian cancer
2007-01-01 Lorenzato A; Coltella N; Olivero M; Martino C; Dettori D; Cossu C; Calogero R; Di Renzo MF
The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C
2011-01-01 Lorenzato A; Martino C; Olivero M; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Di Renzo MF
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Abstract 5900: Tolerance to colibactin correlates with response to chemotherapeutic agents in colorectal cancer | 2023 | Sogari, Alberto; Rovera, Emanuele; Reilly, Nicole Megan; Lamba, Simona; Russo, Mariangela; Lorenzato, Annalisa; Durinikova, Erika; Trusolino, Livio; Arena, Sabrina; Donalisio, Manuela; Nicolantonio, Federica Di; Lembo, David; Bardelli, Alberto | |
| Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer | 2023 | Grasso, Gaia; Marriella, Elisa; Miotto, Martina; Buzo, Kristi; Reilly, Nicole M.; Andrei, Pietro; Vitiello, Pietro P.; Crisafulli, Giovanni; Arena, Sabrina; Rospo, Giuseppe; Corti, Giorgio; Lorenzato, Annalisa; Cancelliere, Carlotta; Barault, Ludovic; Gionfriddo, Giulia; Linnebacher, Michael; Russo, Mariangela; Nicolantonio, Federica Di; Bardelli, Alberto | |
| Cisplatin unveils cancer cell addiction to the non-oncogene CDT2 | 2009 | Olivero M; Dettori D; Lorenzato A; Martino C; Musiani D; Orlando G; Di Renzo MF | |
| CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin | 2010 | Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF | |
| Genetics in renal cancer | 2008 | M. Olivero; A. Lorenzato; Di Renzo MF | |
| MET-oncogene transforms human bone-derived cells by targeting committed progenitors. | 2010 | Dani N; Olivero M; Lorenzato A; Cuvertino S; Patane’ S; Van Duist M; Mareschi K; Fagioli F; Di Renzo MF | |
| P38MAPK highlights the dark side of Met/HGF pathway in ovarian cancer | 2007 | Lorenzato A; Coltella N; Olivero M; Martino C; Dettori D; Cossu C; Calogero R; Di Renzo MF | |
| The cellular apoptosis susceptibility CAS/CSE1L gene specifically protects ovarian cancer cells from death by suppressing RASSF1C | 2011 | Lorenzato A; Martino C; Olivero M; Dani N; Oligschläger Y; Ferrero AM; Biglia N; Calogero R; Di Renzo MF |